Valeriano, Jeric A.
HRN: 20-74-13 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/25/2023
COTRIMOXAZOLE 960MG (TAB)
10/25/2023
10/31/2023
PO
960
OD
Immunocompromised State; Prophylaxis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Febrile NeutropeniaProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes